Microorganisms are main producers of Active Pharmacological ingredients (APIs). Inbiotec is leading since its inception the research in this field, laying the groundwork and developing the innovations which have enabled new and improved industrial processes to achieve better and more affordable medications, from antimicrobials that fight against infectious diseases to immunotherapics enabling organ transplants.